Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Farmacotherapie bij diabetische perifere neuropathie: een systematische review
jul 2017 | Diabetes